Minapharm Pharmaceuticals (MIPH)
Last update: 25 December 02:25 PM market time.
11.12
3.29%
Open
337.86
Previous Close
337.86
High
390.00
Low
345.00
Stock Statistics
Volume
24,871
Turnover
9,065,916.00
All data are 15 minutes late during market session
- Stock
- Company Profile
- News
- Announcements
- Fair Values
- Corporate Actions
- Earning Announcements
- News Reports
- Insider Trades
- Volume Statistics
- Financial Ratios
- IPOs
- Financial Statements
- Support and resistance
- More
General Information
Company Name
Minapharm Pharmaceuticals (MIPH)
Company Purpose
Minapharm Pharmaceuticals is a public company, listed on Egyptian Exchange (EGX) since January 2004. It operates within the pharmaceuticals, biotechnology & life sciences sector focusing on pharmaceuticals. Minapharm Pharmaceuticals is based in Cairo, Egypt and was established in October 1986.
Company Establish Date
01 October 1986
Financial Year Start
First Quarter
Auditor
- Al Maazawy & Co
- Amr Waheed Bayoumi
Ownership
- Triquera BV (79.59%)
- Nihal Saad Albrdesa (0.378%)
- Wafik Saad El Bardisy (0.372%)
- Shaheer Wafik Saad El Bardisy (0.31%)
- Amr Muhamed Subhi Hamza El Shabrawishy (0.177%)
- Anwar Nasr Mikhail (0.1557%)
- Mona Muhamed Subhi Hamza El Shabrawishy (0.102%)
Management
Amr Muhamed Subhi Hamza El Shabrawishy
Deputy Chairman
Represents
Triquera BV
Shaheer Wafik Saad El Bardisy
Managing director
Represents
Triquera BV
Anwar Nasr Mikhail
Board Members
Mahmoud Salim Mahmoud Sayed
Board Members
Nihal Saad Albrdesa
Board Members
Represents
Triquera BV
Ahmed Maher Abdel Halim Rady
Board Members
Represents
Triquera BV
Mona Muhamed Subhi Hamza El Shabrawishy
Board Members
Represents
Triquera BV
Wafik Saad El Bardisy
Represents
Triquera BV
Subsidiaries
- ProBioGen AG (99.19%)
- Minapharm for Trade and Distribution (95.00%)
- Migentra Egypt Healthcare Transforming Medicines (75.01%)
- MiGenTra- GmbH (49.00%)
Contacts
Address
El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo - Egypt
Phone
+20 2 24143171
Fax
+20 2 24143179
Website
www.minapharm.com
Email
[email protected]
Contact Person
Alber Sami Barsom